Jurox – Continuing to support veterinary anaesthesia

Jurox is based in the Hunter Valley, and is an Australian family owned veterinary pharmaceutical company manufacturing in excess of 120 proprietary animal health products.

Jurox, the makers of Australia’s number one anaesthetic agent, Alfaxan®, is dedicated to raising the standards of anaesthesia, supporting clinics with valuable resources and in-clinic training sessions for clinic staff.

With the global launch of Alfaxan Multidose in 2018, Jurox remains committed to the improvement of anaesthesia and analgesia in our veterinary patients and will continue to support veterinarians and their nurses in all aspects of anaesthesia.

The reliability of Alfaxan coupled with its minimal effects on the cardiovascular system makes it a suitable anaesthetic agent for compromised patients1. With this in mind, Jurox is proud to present a new addition to the Alfaxan Library covering the “Use of Alfaxan in Cardiac Disease Patients”. This library piece includes a quick reference guide to anaesthetising cardiac patients, as well as details about the physiological considerations and anaesthetic considerations for these high-risk patients.

Come and visit us at stand 70-71 to collect this new resource and learn more about how our experienced Territory Managers and Technical Services Team can assist your clinic.


  1. Psatha E, Alibhai HI, Jimenez-Lozano A, Armitage-Chan E, Brodbelt DC. Clinical efficacy and cardiorespiratory effects of alfaxalone, or diazepam/fentanyl for induction of anaesthesia in dogs that are a poor anaesthetic risk. Vet Anaesth Analg. 2011 Jan;38(1):24–36.